Verition Fund Management LLC Sage Therapeutics, Inc. Transaction History

Verition Fund Management LLC

$17.4 Billion
Q3 2024

A detailed history of Verition Fund Management LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 136,422 shares of SAGE stock, worth $757,142. This represents 0.01% of its overall portfolio holdings.

Number of Shares

136,422

Previous 137,602 0.86%

Holding current value

$757,142

Previous $1.49 Million 34.2%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $8,283 - $15,434	-1,180 Reduced 0.86%	136,422 $983,000
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $30,121 - $50,961	-2,847 Reduced 2.03%	137,602 $1.49 Million
Q1 2024 May 14, 2024	BUY	$18.62 - $26.95 $148,010 - $214,225	7,949 Added 6.0%	140,449 $2.63 Million
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $218,880 - $284,928	-12,800 Reduced 8.81%	132,500 $2.87 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $103,766 - $303,431	6,195 Added 4.45%	145,300 $2.99 Million
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $81,625 - $119,556	2,008 Added 1.46%	139,105 $6.54 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $90,603 - $113,211	2,431 Added 1.81%	137,097 $5.75 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $70,550 - $95,549	-2,191 Reduced 1.6%	134,666 $5.14 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $107,976 - $144,738	-3,345 Reduced 2.39%	136,857 $5.36 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $3.86 Million - $5.33 Million	140,202 New	140,202 $4.53 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $448,737 - $639,446	-11,146 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $611,692 - $883,766	11,146 New	11,146 $633,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $1.54 Million - $4.56 Million	-59,047 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $3.55 Million - $9.14 Million	59,047 New	59,047 $4.26 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $288,865 - $335,054	-1,830 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $163,473 - $299,479	1,830 New	1,830 $291,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $160,848 - $274,250	-1,963 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$138.11 - $169.04 $271,109 - $331,825	1,963 New	1,963 $277,000
Q2 2018 Aug 15, 2018	SELL	$140.36 - $175.76 $225,418 - $282,270	-1,606 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$152.15 - $192.33 $244,352 - $308,881	1,606 New	1,606 $259,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $330M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Sage Therapeutics, Inc. Transaction History